Expression of both Cdk5 and its activator Cdk5r1 (p35) were increased at the mRNA level in WT CKD but remained near baseline in CG1-KO kidneys in all 3 CKD models tested (Figure 5C and Supplemental Figure 5, A and B). Here, CDK5 is linked to chronic kidney disease.